Healthcare provider profile · identity verified

Virendra Kumar Agarwal, MD

Internal Medicine · GAINESVILLE, TX · NPI 1972590297

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	720	75
Rosuvastatin Calcium	Rosuvastatin Calcium	557	110
Alprazolam	Alprazolam	308	32
Furosemide	Furosemide	288	68
Metoprolol Succinate	Metoprolol Succinate	262	48
Omeprazole	Omeprazole	237	46
Clonazepam	Clonazepam	230	25
Levothyroxine Sodium	Levothyroxine Sodium	212	46
Gabapentin	Gabapentin	195	26
Clopidogrel	Clopidogrel Bisulfate	189	38
Valsartan	Valsartan	166	30
Potassium Chloride	Potassium Chloride	164	38
Torsemide	Torsemide	164	38
Diazepam	Diazepam	159	25
Pregabalin	Pregabalin	154	29
Azithromycin	Azithromycin	150	60
Metformin Hcl	Metformin Hcl	149	30
Amlodipine Besylate	Amlodipine Besylate	148	36
Methadone Hcl	Methadone Hcl	144	20
Propranolol Hcl Er	Propranolol Hcl	142	20
Atenolol	Atenolol	121	30
Atorvastatin Calcium	Atorvastatin Calcium	119	29
Famotidine	Famotidine	114	22
Glimepiride	Glimepiride	113	21
Sertraline Hcl	Sertraline Hcl	113	19
Tamsulosin Hcl	Tamsulosin Hcl	108	18
Citalopram Hbr	Citalopram Hydrobromide	104	15
Carvedilol	Carvedilol	99	20
Tizanidine Hcl	Tizanidine Hcl	98	17
Duloxetine Hcl	Duloxetine Hcl	97	18
Warfarin Sodium	Warfarin Sodium	94	11
Albuterol Sulfate Hfa	Albuterol Sulfate	91	28
Spironolactone	Spironolactone	89	26
Lorazepam	Lorazepam	88	11
Allopurinol	Allopurinol	87	15
Metoclopramide Hcl	Metoclopramide Hcl	82	26
Lisinopril	Lisinopril	77	16
Doxazosin Mesylate	Doxazosin Mesylate	76	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	76	suppressed
Prednisone	Prednisone	76	36
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	75	20
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	73	20
Estradiol (Once Weekly)	Estradiol	73	suppressed
Losartan Potassium	Losartan Potassium	69	17
Aripiprazole	Aripiprazole	61	suppressed
Oxycodone Hcl	Oxycodone Hcl	61	suppressed
Nifedipine Er	Nifedipine	59	suppressed
Trazodone Hcl	Trazodone Hcl	56	suppressed
Tramadol Hcl	Tramadol Hcl	53	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	52	suppressed
Fluticasone Propionate	Fluticasone Propionate	47	21
Testosterone Cypionate	Testosterone Cypionate	47	suppressed
Prasugrel Hcl	Prasugrel Hcl	44	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	43	15
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	31
Fluoxetine Hcl	Fluoxetine Hcl	39	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	37	24
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Methotrexate	Methotrexate Sodium	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Terbinafine Hcl	Terbinafine Hcl	36	20
Divalproex Sodium	Divalproex Sodium	34	suppressed
Eliquis	Apixaban	34	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Dutasteride-Tamsulosin	Dutasteride/Tamsulosin Hcl	31	suppressed
Estradiol	Estradiol	31	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	29	suppressed
Dutasteride	Dutasteride	29	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Dexamethasone	Dexamethasone	26	19
Ketoconazole	Ketoconazole	25	15
Mirtazapine	Mirtazapine	25	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	25	suppressed
Solifenacin Succinate	Solifenacin Succinate	25	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Divalproex Sodium Er	Divalproex Sodium	23	suppressed
Promethazine Hcl	Promethazine Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	16
Ozempic	Semaglutide	20	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	19	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	18	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	16
Ezetimibe	Ezetimibe	17	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	17	suppressed
Levofloxacin	Levofloxacin	17	14
Montelukast Sodium	Montelukast Sodium	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	11
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Temazepam	Temazepam	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Calcium Acetate	Calcium Acetate	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	13
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Humulin N	Insulin Nph Human Isophane	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Risperidone	Risperidone	13	suppressed
Simvastatin	Simvastatin	13	suppressed
Baclofen	Baclofen	12	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Fentanyl	Fentanyl	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	11	suppressed
Novolin N	Insulin Nph Human Isophane	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error